VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HESLOP, HELEN
One or more keywords matched the following items that are connected to
HESLOP, HELEN
Item Type
Name
Academic Article
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.
Academic Article
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.
Academic Article
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.
Academic Article
Gene marking after bone marrow transplantation.
Academic Article
Adoptive cellular immunotherapy for EBV lymphoproliferative disease.
Academic Article
EBV specific CTL: a model for immune therapy.
Academic Article
Immunotherapy for Epstein-Barr virus-associated cancers.
Academic Article
Gene therapy of pediatric leukemia.
Academic Article
Gene and cell transfer for specific immunotherapy.
Academic Article
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.
Academic Article
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.
Academic Article
Use of gene marking in bone marrow transplantation.
Academic Article
Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines.
Academic Article
Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation.
Academic Article
Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.
Academic Article
Gene transfer for the therapy of hematologic malignancy.
Academic Article
Immunotherapy for Hodgkin's disease.
Academic Article
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.
Academic Article
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy.
Academic Article
Upper airway obstruction and pulmonary abnormalities due to lymphoproliferative disease following bone marrow transplantation in children.
Academic Article
The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.
Academic Article
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.
Academic Article
Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes.
Academic Article
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.
Academic Article
Gene-marking studies of hematopoietic cells.
Academic Article
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.
Academic Article
Immunotherapy for Epstein-Barr virus-associated cancers in children.
Academic Article
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
Academic Article
Adoptive cellular immunotherapy for viral diseases.
Academic Article
The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
Academic Article
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.
Academic Article
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
Academic Article
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.
Academic Article
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.
Academic Article
Adoptive immunotherapy for posttransplantation viral infections.
Academic Article
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.
Academic Article
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
Academic Article
Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.
Academic Article
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.
Academic Article
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.
Academic Article
Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
Academic Article
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
Academic Article
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
Academic Article
T cell therapies.
Academic Article
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
Academic Article
Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
Academic Article
The clone ranger?
Academic Article
Immunotherapy targeting EBV-expressing lymphoproliferative diseases.
Academic Article
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
Academic Article
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).
Academic Article
How I treat EBV lymphoproliferation.
Academic Article
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
Academic Article
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
Academic Article
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.
Academic Article
Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).
Academic Article
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.
Academic Article
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
Academic Article
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.
Academic Article
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
Academic Article
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.
Academic Article
T-cell therapy in the treatment of post-transplant lymphoproliferative disease.
Academic Article
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma.
Academic Article
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.
Academic Article
Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.
Academic Article
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.
Academic Article
Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.
Academic Article
Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.
Academic Article
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.
Academic Article
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.
Academic Article
Prompt versus preemptive intervention for EBV lymphoproliferative disease.
Academic Article
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
Academic Article
Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.
Academic Article
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
Academic Article
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
Academic Article
Cytotoxic T lymphocytes as immune-therapy in haematological practice.
Academic Article
Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.
Academic Article
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
Academic Article
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.
Concept
T-Lymphocytes, Cytotoxic
Academic Article
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
Academic Article
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
Academic Article
T-cell therapy for viral infections.
Academic Article
T lymphocytes targeting native receptors.
Academic Article
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
Academic Article
Reply to S. Yuan et al.
Academic Article
Survivin-specific T cell receptor targets tumor but not T cells.
Academic Article
Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.
Academic Article
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.
Grant
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
Grant
ENHANCING T CELL THERAPY OF CANCER
Search Criteria
T Lymphocytes Cytotoxic